Estimated potency of casodex: A problematic design [1] (multiple letters)

Urology

Volumn 50, Issue 2, 1997, Pages 309-312

  Labrie, F ^a   Simard, J ^a   Singh, S M ^a   Candas, B ^a   Schellhammer, P F ^a   Block, N L ^a   Sharifi, R ^a   Soloway, M S ^a   Patterson, A L ^a   Vogelzang, N J ^a   Sarosdy, M F ^a   Furr, B ^a   Caplan, R ^a   Kolvenbag, G J C M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; FLUTAMIDE; GONADORELIN AGONIST; LUTEINIZING HORMONE; NILUTAMIDE; TESTOSTERONE;

CANCER SURVIVAL; DIARRHEA; DRUG ACTIVITY; DRUG POTENCY; DRUG TOLERABILITY; HORMONAL THERAPY; HUMAN; LETTER; LUTEINIZING HORMONE RELEASE; ORCHIECTOMY; PHARMACODYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE RELEASE; TREATMENT FAILURE;

ANDROGEN ANTAGONISTS; ANILIDES; FLUTAMIDE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0030752425     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)